Gsa Capital Partners LLP Pa Vmed Inc. Transaction History

Gsa Capital Partners LLP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.85 - $1.41 $136,692 - $226,749	-160,815 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$1.16 - $2.5 $13,607 - $29,327	11,731 Added 7.87%	160,815 $212,000
Q4 2021 Feb 14, 2022	BUY	$2.46 - $8.74 $366,746 - $1.3 Million	149,084 New	149,084 $367,000

2.24M

Ticker PAVM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 90,999,104
Market Cap $93.7M
Description
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.